HRT FINANCIAL LP

Position in AMPH — Amphastar Pharmaceuticals, Inc.

CIK 1475597 NEW YORK, NY

Position in AMPH

as of Mar 31, 2026 · filed May 14, 2026 Compact

Position Value

$1,100,585

-$971,345 QoQ

Shares Held

56,181

-27.7% QoQ

Ownership

0.127%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Jun 2020

13 quarters on record

Voting authority Sole 100.ToString("F0")% Shared 0.ToString("F0")% None 0.ToString("F0")%

Healthcare · as of Mar 31, 2026

HRT FINANCIAL LP holds $86,437,876 across 27 Drug Manufacturers - Specialty & Generic names. AMPH ranks #15 (1.3% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	UTHR	UNITED THERAPEUTICS Corp	66,842	$39,635,969
2	HLN	Haleon plc	1,100,190	$11,012,901
3	HIMS	Hims & Hers Health, Inc.	284,622	$5,908,752
4	TEVA	Teva Pharmaceutical Industries Ltd	140,222	$4,223,486
5	NBIX	Neurocrine Biosciences Inc	26,404	$3,478,462
6	LQDA	Liquidia Corp	86,687	$3,271,567
7	ALKS	Alkermes plc.	81,989	$2,899,131
8	TAK	Takeda Pharmaceutical Co Ltd	126,074	$2,334,890

13 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$1,100,585	56,181	-27.7%	Shares	Defined	2026-05-14
2025-09-30	$2,071,930	77,746	+84.8%	Shares	Defined	2025-11-14
2025-06-30	$966,156	42,080	-51.3%	Shares	Defined	2025-08-14
2025-03-31	$2,503,692	86,364	+364.1%	Shares	Defined	2025-05-15
2024-03-31	$817,077	18,608	+85.0%	Shares	Defined	2024-05-13
2023-09-30	$462,521	10,057	+66.8%	Shares	Defined	2023-11-13
2023-06-30	$346,486	6,029	-81.1%	Shares	Defined	2023-08-11
2023-03-31	$1,198,012	31,947	+80.6%	Shares	Defined	2023-05-12
2022-12-31	$495,757	17,693	+43.4%	Shares	Defined	2023-02-10
2022-06-30	$429,308	12,340	-13.8%	Shares	Defined	2022-08-12
2021-09-30	$272,128	14,315	-60.3%	Shares	Defined	2021-11-15
2021-06-30	$726,727	36,048	+209.3%	Shares	Defined	2021-08-16
2020-06-30	$261,748	11,654	—	Shares	Defined	2020-08-14
No filing history on record for this holder in this stock.